| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
From the Physiologisches Institut (S.E.W., C.d.W.), Universität Lübeck; and the Physiologisches Institut (D.S., M.K., U.P.), Ludwig-Maximilians-Universität München, Germany.
Correspondence to Dr Cor de Wit, Physiologisches Institut Universität Lübeck Ratzeburger Allee 160 23538 Lübeck, Germany. E-mail dewit{at}uni-luebeck.de
| Abstract |
|---|
|
|
|---|
Key Words: microcirculation endothelium-dependent hyperpolarizing factor myoendothelial coupling gap junctions acetylcholine-induced hyperpolarization
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
5 mm using a stereo microscope (Leitz, Wetzlar, Germany). Thereafter, the animal was transferred onto a microscope stage (ZEISS, Axioskop FS, Göttingen, Germany), positioned on a movable platform (Luigs & Neumann, Ratingen, Germany) and a vibration-isolated table. A glass microelectrode (80 to 120 M
, filled with 3 mol/L KCl containing 5% carboxyfluorescein in the tip), connected to a membrane potential amplifier (SEC 1L, NPI Advanced Electronics, Tamm, Germany), was positioned vertical to the vessel axis and advanced using an electronic micromanipulator equipped with a piezo stepper (PM 20H, Samwoo Scientific Co, Seoul, South Korea). An Ag/AgCl pellet positioned in the superfusion solution served as the reference electrode. The successful impalement of the cell was verified by a sharp deflection of the potential recording, a low resistance over the cell membrane measured by the application of a test pulse, and a stable potential for at least 30 s. The cell type being impaled was analyzed following each recording by the pattern of cell labeling with carboxyfluorescein, which enabled the identification of the cell by its orientation relative to the vessel axis. Data were collected with a computer based monitoring system (XmAD) at a sampling rate of 1000 Hz and stored for later analysis. In a subset of experiments, arteriolar diameter changes on ACh were assessed in the cremaster microcirculation as described.15 In each animal, 7 to 12 arterioles were monitored, microscopic images projected on a charge-coupled video camera, and displayed on a monitor and recorded on videotape for later measurement of luminal diameters. All mice were euthanized by an overdose of anesthesia at the end of the experimental protocol.
Experimental Protocols
Membrane Potential Measurement
After a postoperative stabilization period of 30 minutes, measurements of membrane potential were started. On successful cell penetration and recording of the resting membrane potential for 30 s, the vessel was stimulated by agonist application via a glass micropipette with a tip of 1 to 3 µm positioned in close proximity to the arteriolar wall. The stimulation pipette was usually placed at a distance between 50 and 600 µm from the measurement electrode. Acetylcholine (10 mmol/L) or sodium-nitroprusside (SNP) (10 mmol/L) was applied by pressure ejection (150 kPa) for increasing periods of time (from 10 to 1000 ms) to achieve increasing local concentrations. Before application of the next pressure pulse, membrane potential was allowed to return to baseline level. Potential recordings from EC were generally more stable over time as compared with smooth muscle cells. Recordings that were not stable for more than 2 minutes were excluded from data analysis. Typically, measurements lasted for
5 minutes before the pipette dislodged spontaneously or the protocol was finished. In general, we were able to obtain 4 to 10 recordings from a single experiment during a 4-hour period in 2 to 4 arterioles. In a subgroup of experiments, after obtaining recordings in nontreated preparations, blockers of KCa were applied onto the arteriole under investigation. This was done using a second glass pipette with a larger tip opening (5 to 10 µm) filled with charybdotoxin (ChTx), iberiotoxin (IbTx), or apamin (Apa) (100 µmol/L) and repeated pressure ejections (150 kPa, 300 ms, 10 to 20 times). Thereafter, vascular cells were again impaled and a similar protocol used. The likelihood to impale EC was higher, but recordings from both cell types were obtained before and after treatment in the same, equally treated animals.
Measurement of Diameter Changes
The cremaster was superfused continuously with the cyclooxygenase inhibitor indomethacin (3 µmol/L) and in a subset of experiments the NO synthase inhibitor N-nitro-L-arginine (L-NA) (30 µmol/L) 30 minutes before the protocol was started and throughout the experiment. Arteriolar diameters were measured shortly before and during the local superfusion of ACh (1, 3, 10 µmol/L). Increasing concentrations were applied consecutively, with a recovery period of 5 minutes between washout and application of the next concentration or drug. During this recovery period, the arterioles regained their baseline diameter. The same protocol was then repeated after application of IbTx and/or Apa (0.1 µmol/L) to the superfusion solution for 20 minutes. Additionally, responses on application of SNP (3, 10 µmol/L) were studied. The maximal diameter of the arterioles was obtained during superfusion of a combination of different vasodilators (adenosine [100 µmol/L], SNP [100 µmol/L], and ACh [100 µmol/L]) at the end of the experimental protocol.
Statistics and Calculations
Vascular tone is given as the quotient of the resting diameter of the vessel divided by its maximum. Changes of the inner diameter of the vessels were normalized to the maximal possible constriction or dilation according to the relationship: percentage of maximal response=(DTrDCo)/(DMDCo)x100, where DTr is the diameter observed after treatment and DCo is the control diameter before treatment. DM is (for dilator responses) the diameter at maximal dilation or (for constrictions) the minimal luminal diameter (0). Comparisons within groups were performed using paired t tests, and, for multiple comparisons, probability values were corrected according to Bonferroni. Data between groups were compared by analysis of variance followed by post hoc analysis of the means, with P<0.05 considered significant. Data are presented as mean±SEM.
| Results |
|---|
|
|
|---|
|
|
ACh-Induced Hyperpolarization and Effect of Blockers of KCa
The local application of ACh induced robust hyperpolarizations in EC and SMC. Figure 3 shows a representative example of a measurement of the membrane potential in an EC and SMC, respectively. Each bolus application of ACh induced a hyperpolarization, which increased in amplitude and duration in EC with increasing pulse duration leading to higher, but unknown local ACh concentrations. This increment was less pronounced in SMC (Figure 3). Because the local ACh concentration after a pressure-pulse is difficult to predict in different experiments, the data were divided in 4 groups of stimulation according to pulse duration. With a pressure pulse between 10 and 50 ms (32±1 ms), EC hyperpolarized from 47.9±0.8 to 56.2±0.9 mV, between 51 and 200 ms (120±5 ms) from 49.7±0.9 to 59.6±0.8 mV, between 201 and 700 ms (457±11 ms) from 46.8±1.0 to 57.3±1.1 mV, and >700 ms (1250±67 ms) from 45.4±1.4 to 57.3±1.4 mV. The duration of the pressure pulses were not different in SMC, which hyperpolarized from 39.3±2.4 to 43.5±2.0 mV at 31±4 ms, from 40.6±1.6 to 45.7±1.9 mV at 137±10 ms, from 35.3±1.8 to 40.1±2.1 mV at 458±17 ms, and from 39.3±3.5 to 44.3±3.2 mV at 1333±167 ms of stimulation duration. The amplitudes of membrane-potential changes with different pulse durations are depicted in Figure 4. The difference with increasing stimulus duration seen in an individual EC is reflected in the summary data as a significantly larger amplitude in the group with the longest pressure pulse as compared with the group with the shortest stimulation duration. In SMC, an increase in amplitude with the stimulation duration was not found. However, the response duration was enhanced with increasing stimulation duration in EC, an effect that was also found in SMC. Most interestingly, amplitude and duration were enhanced in EC as compared with SMC (Figure 4), showing a distinct response in each cell type. In 3 animals, responses in EC were also measured >1 mm upstream of the ACh stimulation site. Also at this distance (1210±20 µm), a significant hyperpolarization was observed in EC on remote stimulation with ACh (by 3.7±0.3 mV at 89±20 ms and by 5.3±0.2 mV at 1318±245 ms). The NO-donor SNP applied by a pressure pulse at the site of recording did not induce changes of membrane potential in SMC (30.6±2.0 to 30.1±2.0 mV, n=14) but resulted in a small hyperpolarization in EC (39.6±1.5 to 40.2±1.5 mV, n=33, P<0.05).
|
|
To study the type of K+ channels involved in the ACh-induced hyperpolarization, blockers of KCa were applied locally onto the vessel wall. After ChTx, EC hyperpolarization remained unaffected. EC hyperpolarized before ChTx from 47.8±2.5 to 57.6±2.8 mV (P<0.05, n=13 in 6 experiments) at 319±57 ms ACh pressure pulse and after ChTx from 54.6±2.7 to 62.8±3.0 mV (P<0.05, n=14 in 6 experiments) at a stimulus duration of 315±69 ms. Likewise, the duration of the response in EC was not altered (before: 6.6±0.9 s; after: 5.7±0.7 s; P=0.43). SMC hyperpolarized from 45.0±4.4 to 52.7±3.0 mV (P<0.05; n=7 in 6 experiments) in this group under control conditions, but, in contrast to EC, the ACh-induced hyperpolarization was completely abrogated after ChTx (from 35.2±2.3 to 36.6±2.1 mV, P=0.13, n=8; Figure 5). The specific blocker of large conductance KCa (BKCa), IbTx, produced similar results: the hyperpolarization of EC in response to ACh was unaffected, whereas the hyperpolarization in SMC was abrogated after IbTx (Figures 5 and 6
). After local treatment with Apa, a blocker of SKCa, a reverse pattern of inhibition was observed. EC hyperpolarized on ACh from 42.8±2.2 to 49.2±2.7 mV (P<0.05, n=10) in this group under control conditions, and this hyperpolarization was blocked after Apa (from 41.6±2.2 to 42.9±2.1 mV, P=0.10, n=16, Figure 5). In contrast to EC, the maximal amplitude of the small hyperpolarization in SMC was unaffected by Apa (Figure 6, n=5), although the onset of the hyperpolarization was delayed (Figure 5). Of all antagonists, only ChTx affected the resting membrane potential in vascular cells. SMC were significantly depolarized after ChTx (from 45.6±4.3 to 34.6±1.6 mV), but no significant change was found in EC (before: 50.3±2.3; after 54.7±2.5 mV; P=0.21). IbTx did not change the membrane potential of EC (51.3±3.9 versus 54.5±2.9 mV) or SMC (37.5±2.7 versus 33.8±2.3 mV), and also Apa was without effect (EC: 43.6±2.4 versus 42.0±2.3 mV; SMC 34.4±4.2 versus 35.9±0.8 mV). However, it has to be kept in mind that these measurements were not performed continuously during drug application, and because of the variation in resting membrane potentials, small changes in response to the blockers cannot be verified.
|
|
Effect of K+-Channel Blockers on ACh-Induced Dilations
In a different group of mice, the effect of the KCa-channel blockers on ACh-induced diameter changes was studied. The maximal diameter of the arterioles studied was 23±1 µm. Superfusion of ACh induced a concentration-dependent dilation in the presence of L-NA and indomethacin (30 and 3 µmol/L). This dilation was attenuated after the application of IbTx (0.1 µmol/L, Figure 7). IbTx reduced the ACh-induced dilation also in the absence of L-NA to a similar amount, and the subsequent addition of L-NA (30 µmol/L) had no additional inhibitory effect (Figure 7). In vessels treated with L-NA and indomethacin, Apa (0.1 µmol/L) also attenuated the ACh-induced dilations but to a lesser extent than IbTx. However, the subsequent addition of IbTx induced a further reduction of the ACh-induced responses to a level that was not different from that observed in vessels treated only with IbTx (Figure 7). The dilation induced by the NO-donor SNP (10 µmol/L) remained unaffected by IbTx and/or Apa (control: 79±3%; IbTx: 78±3%; Apa: 84±2%; Apa and IbTx: 79±2%). Likewise, smaller dilations induced by SNP (3 µmol/L), which were comparable to the dilation induced by 3 µmol/L ACh, were not attenuated in the presence of IbTx (56±5 versus 57±5%; n=32 arterioles in 3 experiments). However, IbTx induced a significant constriction in resting vessels in the absence of L-NA (8±3%, P<0.05), and this constriction was also observed in vessels treated with L-NA (10±4%, P<0.05).
|
| Discussion |
|---|
|
|
|---|
The importance of hyperpolarizations in eliciting dilations in response to endothelium-dependent agonists (eg, ACh) has been extensively documented.1,2 Aside from various factors that have been implicated to be released from EC, myoendothelial coupling via gap junctions has been proposed to transfer the hyperpolarization between EC and SMC directly.1820 However, the evidence for this was obtained mostly in isolated vessels and it is unclear whether such communication is also found in vivo. The data from the present study suggest that electrical myoendothelial coupling is not prominent in arterioles of the murine skeletal muscle in vivo because the resting membrane potential in EC and SMC was significantly different. Whereas the resting potential of SMC was in a similar range as reported for cheek pouch arterioles of the hamster in vivo,28 EC exhibited a more negative potential. However, the comparison of resting membrane potentials of vascular cells is hindered by the fact that values reported from different vessels and preparations obtained in vitro are substantially different. If a tight myoendothelial coupling exists, the 2 cell layers should exhibit similar membrane potentials, a finding that is very common in vessels in vitro.18
In response to ACh stimulation, we found a robust hyperpolarization in both cell types. This hyperpolarization was larger in amplitude and in duration in EC than SMC, again demonstrating a different behavior that is in contrast to hyperpolarizations obtained in vitro, which are reported to be indistinguishable from each other.18 However, an attenuation of the amplitude in SMC might be attributable to an ohmic resistor represented by myoendothelial gap junctions and solely this observation does not exclude current transfer. To our knowledge, only 1 study has addressed this question in vivo, and these authors also observed slightly different responses in EC and SMC in the hamster microcirculation.28 Further proof for a lack of tight myoendothelial coupling in vivo was added by studying conducted dilations during selective destruction of the endothelial or smooth muscle layer.30 The contrasting results from work done in vivo versus in vitro is surprising and requires explanation. As vessels studied in vitro are generally larger than arterioles studied in the microcirculation in vivo, it is difficult to decide whether differences in myoendothelial coupling are solely attributable to this fact, eg, different vessel sizes. Clearly, the presence of myoendothelial junctions varies with the type and size of vessel studied.21,31 The measurement of membrane potential required the careful dissection of the arterioles from the surrounding skeletal muscle. This inevitable artifact and the impalement of the cell might have resulted in an uncoupling of the 2 cell layers. However, the fact that EC responded to ACh stimulation of the arteriole at a remote, distant site argues against a sole uncoupling of the impaled cell from its neighbors. Moreover, the lack of tight myoendothelial coupling might be specific for this vascular bed (cremaster muscle), as most in vitro data demonstrating strong myoendothelial coupling were obtained in vessels from other tissues. Alternatively, in vivo, a mechanism is active that regulates communication between the cell layers. Such a mechanism might involve flow or shear stress, as membrane potential measurements in vitro are usually performed in the absence of flow. As outlined before, resting membrane potentials, especially of EC, were more hyperpolarized in vivo, and simply this fact might affect myoendothelial communication. Other candidates for the regulation of (myoendothelial) gap junctions are the second messengers cAMP32 or EETs.33 Whatever the exact nature of the mechanism is, we propose that in vivo, a tight control of the SMC membrane potential by direct current transfer from EC is prevented.
We used selective blockers to identify the K+ channels that are activated to induce the hyperpolarizations on ACh. Apa, a specific blocker of SKCa, completely prevented the hyperpolarization in EC. In contrast, hyperpolarization in SMC was sensitive to ChTx, which blocks IKCa and BKCa, but was also sensitive to the more specific blocker of BKCa, IbTx. These latter blockers did not alter the endothelial hyperpolarizations, suggesting that SMC hyperpolarization was not transmitted from EC via gap junctions but was attributable to the activation of BKCa by an unknown diffusible factor. Activation of this channel has been attributed to EETs in other vessels.1 However, in a previous study, we were not able to attenuate ACh dilations with blockers of the cytochrome P450 pathway.15 The factor that activates BKCa thus remains elusive. However, the present study suggests that myoendothelial junctions are not involved and that BKCa acts as an important mediator of the mechanical response by inducing SMC hyperpolarization. The efficacy of IbTx to block hyperpolarizations in SMC was mirrored by its effect on mechanical responses as IbTx strongly reduced ACh-dilations. IbTx also reduced the vessels resting diameter suggesting a continuous dilator effect by activation of these channels. Nevertheless, we were not able to find a significant depolarization in response to IbTx, whereas ChTx did induce a depolarization in SMC. However, it has to be kept in mind that the membrane potential was not measured continuously during application of these blockers, but single cells were impaled before and after drug application. This might leave subtle changes of the membrane potential undetected because of the variation of the membrane potential of the cells.
The important contribution of SKCa in EC to the resting membrane potential and vascular tone has been demonstrated previously in an elegant model using genetic alteration of channel expression.34 In this study, we demonstrated the importance of this channel for the endothelial hyperpolarization elicited by ACh. However, Apa only attenuated the EDHF-type dilation in the cremaster arterioles, and its effect was smaller as compared with the effect of IbTx (Figure 7). Most importantly, the blocking potency of Apa and IbTx was not independent as IbTx was equally effective with or without Apa. These findings suggest that the activation of SKCa is contributing to the mechanical response and serves to activate an EDHF-type dilation, which is in line with many previous reports.
In summary, we conclude that myoendothelial coupling is not dominant in vivo, as shown by measuring the membrane potential. This is in contrast to data obtained in vitro. The mechanism that downregulates myoendothelial coupling in vivo remains obscure and requires further study. We propose that flow or shear stress might be involved and possibly include NO. Although the regulation of cellular coupling is still poorly understood, it appears to be physiologically important and might explain differences obtained in vivo versus in vitro. From a physiological perspective, a fine-tuned regulation of membrane potential and the possibility to modify it between EC and SMC seems plausible and supports specific cellular functions in the microcirculation. However, this leaves the question as to the mechanisms and possible factors by which EC act to change the membrane potential of SMC still open.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Griffith TM. Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis? Br J Pharmacol. 2004; 141: 881903.[CrossRef][Medline] [Order article via Infotrieve]
3. Quignard JF, Feletou M, Edwards G, Duhault J, Weston AH, Vanhoutte PM. Role of endothelial cell hyperpolarization in EDHF-mediated responses in the guinea-pig carotid artery. Br J Pharmacol. 2000; 129: 11031112.[CrossRef][Medline] [Order article via Infotrieve]
4. Eichler I, Wibawa J, Grgic I, Knorr A, Brakemeier S, Pries AR, Hoyer J, Kohler R. Selective blockade of endothelial Ca2+-activated small- and intermediate-conductance K+-channels suppresses EDHF-mediated vasodilation. Br J Pharmacol. 2003; 138: 594601.[CrossRef][Medline] [Order article via Infotrieve]
5. Bychkov R, Burnham MP, Richards GR, Edwards G, Weston AH, Feletou M, Vanhoutte PM. Characterization of a charybdotoxin-sensitive intermediate conductance Ca2+-activated K+ channel in porcine coronary endothelium: relevance to EDHF. Br J Pharmacol. 2002; 137: 13461354.[CrossRef][Medline] [Order article via Infotrieve]
6. Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH. K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 1998; 396: 269272.[CrossRef][Medline] [Order article via Infotrieve]
7. Weston AH, Richards GR, Burnham MP, Feletou M, Vanhoutte PM, Edwards G. K+-induced hyperpolarization in rat mesenteric artery: identification, localization and role of Na+/K+-ATPases. Br J Pharmacol. 2002; 136: 918926.[CrossRef][Medline] [Order article via Infotrieve]
8. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R. Cytochrome P4502C is an EDHF synthase in coronary arteries. Nature. 1999; 401: 493497.[CrossRef][Medline] [Order article via Infotrieve]
9. Nishikawa Y, Stepp DW, Chilian WM. In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation. Am J Physiol. 1999; 277: H1252H1259.[Medline] [Order article via Infotrieve]
10. Bolz SS, Fisslthaler B, Pieperhoff S, de Wit C, Fleming I, Busse R, Pohl U. Antisense oligonucleotides against cytochrome P450 2C8 attenuate EDHF-mediated Ca2+ changes and dilation in isolated resistance arteries. FASEB J. 2000; 14: 255260.
11. de Wit C, Esser N, Lehr HA, Bolz SS, Pohl U. Pentobarbital sensitive EDHF comediates ACh-induced arteriolar dilation in the hamster microcirculation. Am J Physiol. 1999; 276: H1527H1534.[Medline] [Order article via Infotrieve]
12. Huang A, Sun D, Smith CJ, Connetta JA, Shesely EG, Koller A, Kaley G. In eNOS knockout mice skeletal muscle arteriolar dilation to acetylcholine is mediated by EDHF. Am J Physiol Heart Circ Physiol. 2000; 278: H762H768.
13. Gauthier KM, Deeter C, Krishna UM, Reddy YK, Bondlela M, Falck JR, Campbell WB. 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ Res. 2002; 90: 10281036.
14. Brandes RP, Schmitz-Winnenthal FH, Feletou M, Gödecke A, Huang PL, Vanhoutte PM, Fleming I, Busse R. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci U S A. 2000; 97: 97479752.
15. Koeppen M, Feil R, Siegl D, Feil S, Hofmann F, Pohl U, de Wit C. cGMP-dependent protein kinase mediates NO- but not acetylcholine-induced dilations in resistance vessels in vivo. Hypertension. 2004; 44: 952955.
16. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest. 2000; 106: 15211530.[Medline] [Order article via Infotrieve]
17. Chauhan SD, Nilsson H, Ahluwalia A, Hobbs AJ. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc Natl Acad Sci U S A. 2003; 100: 14261431.
18. Emerson GG, Segal SS. Electrical coupling between endothelial cells and smooth muscle cells in hamster feed arteries. Role in vasomotor control. Circ Res. 2000; 87: 474479.
19. Coleman HA, Tare M, Parkington HC. EDHF is not K+ but may be due to spread of current from the endothelium in guinea pig arterioles. Am J Physiol Heart Circ Physiol. 2001; 280: H2478H2483.
20. Sandow SL, Tare M, Coleman HA, Hill CE, Parkington HC. Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor. Circ Res. 2002; 90: 11081113.
21. Sandow SL, Hill CE. Incidence of myoendothelial gap junctions in the proximal and distal mesenteric arteries of the rat is suggestive of a role in endothelium-derived hyperpolarizing factor-mediated responses. Circ Res. 2000; 86: 341346.
22. Sandow SL, Looft-Wilson R, Doran B, Grayson TH, Segal SS, Hill CE. Expression of homocellular and heterocellular gap junctions in hamster arterioles and feed arteries. Cardiovasc Res. 2003; 60: 643653.
23. Dora KA, Sandow SL, Gallagher NT, Takano H, Rummery NM, Hill CE, Garland CJ. Myoendothelial gap junctions may provide the pathway for EDHF in mouse mesenteric artery. J Vasc Res. 2003; 40: 480490.[CrossRef][Medline] [Order article via Infotrieve]
24. Chaytor AT, Martin PEM, Edwards DH, Griffith TM. Gap junctional communication underpins EDHF-type relaxations evoked by ACh in the rat hepatic artery. Am J Physiol Heart Circ Physiol. 2001; 280: H2441H2450.
25. Hutcheson IR, Chaytor AT, Evans WH, Griffith TM. Nitric oxide independent relaxations to acetylcholine and A23187 involve different routes of heterocellular communication. Role of gap junctions and phospholipase A(2). Circ Res. 1999; 84: 5363.
26. Chaytor AT, Evans WH, Griffith TM. Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries. J Physiol. 1998; 508: 561573.
27. Yamamoto Y, Klemm MF, Edwards FR, Suzuki H. Intercellular electrical communication among smooth muscle and endothelial cells in guinea-pig mesenteric arterioles. J Physiol. 2001; 535: 181195.
28. Welsh DG, Segal SS. Endothelial and smooth muscle cell conduction in arterioles controlling blood flow. Am J Physiol. 1998; 274: H178H186.[Medline] [Order article via Infotrieve]
29. de Wit C, Roos F, Bolz SS, Kirchhoff S, Krüger O, Willecke K, Pohl U. Impaired conduction of vasodilation along arterioles in connexin40 deficient mice. Circ Res. 2000; 86: 649655.
30. Budel S, Bartlett IS, Segal SS. Homocellular conduction along endothelium and smooth muscle of arterioles in hamster cheek pouch: unmasking an NO wave. Circ Res. 2003; 93: 6168.
31. Sandow SL, Goto K, Rummery NM, Hill CE. Developmental changes in myoendothelial gap junction mediated vasodilator activity in the rat saphenous artery. J Physiol. 2004; 556: 875886.
32. Griffith TM, Chaytor AT, Taylor HJ, Giddings BD, Edwards DH. cAMP facilitates EDHF-type relaxations in conduit arteries by enhancing electrotonic conduction via gap junctions. Proc Natl Acad Sci U S A. 2002; 99: 63926397.
33. Popp R, Brandes RP, Ott G, Busse R, Fleming I. Dynamic modulation of interendothelial gap junctional communication by 11,12-epoxyeicosatrienoic acid. Circ Res. 2002; 90: 800806.
34. Taylor MS, Bonev AD, Gross TP, Eckman DM, Brayden JE, Bond CT, Adelman JP, Nelson MT. Altered expression of small-conductance Ca2+-activated K+ (SK3) channels modulates arterial tone and blood pressure. Circ Res. 2003; 93: 124131.
This article has been cited by other articles:
![]() |
S. E. Wolfle, V. J. Schmidt, J. Hoyer, R. Kohler, and C. de Wit Prominent role of KCa3.1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo Cardiovasc Res, June 1, 2009; 82(3): 476 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Isakson, A. K. Best, and B. R. Duling Incidence of protein on actin bridges between endothelium and smooth muscle in arterioles demonstrates heterogeneous connexin expression and phosphorylation Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2898 - H2904. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Parkington, M. Tare, and H. A. Coleman The EDHF Story: The Plot Thickens Circ. Res., May 23, 2008; 102(10): 1148 - 1150. [Full Text] [PDF] |
||||
![]() |
C. E. Hill Inward rectification and vascular function: As it was in the beginning J. Physiol., March 15, 2008; 586(6): 1465 - 1467. [Full Text] [PDF] |
||||
![]() |
S. E. Wolfle, V. J. Schmidt, B. Hoepfl, A. Gebert, S. Alcolea, D. Gros, and C. de Wit Connexin45 Cannot Replace the Function of Connexin40 in Conducting Endothelium-Dependent Dilations Along Arterioles Circ. Res., December 7, 2007; 101(12): 1292 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. F. Figueroa and B. R. Duling Reply to "Letter to the editor: 'Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone?'" Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H2008 - H2008. [Full Text] [PDF] |
||||
![]() |
X. F. Figueroa, C.-C. Chen, K. P. Campbell, D. N. Damon, K. H. Day, S. Ramos, and B. R. Duling Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1371 - H1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rodenwaldt, U. Pohl, and C. de Wit Endogenous and exogenous NO attenuates conduction of vasoconstrictions along arterioles in the microcirculation Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2341 - H2348. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Domeier and S. S. Segal Electromechanical and pharmacomechanical signalling pathways for conducted vasodilatation along endothelium of hamster feed arteries J. Physiol., February 15, 2007; 579(1): 175 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, C. Cao, M. Mangano, Z. Zhang, E. P. Silldorff, W. Lee-Kwon, K. Payne, and T. L. Pallone Descending vasa recta endothelium is an electrical syncytium Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1688 - R1699. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. F. Figueroa, B. E. Isakson, and B. R. Duling Vascular Gap Junctions in Hypertension Hypertension, November 1, 2006; 48(5): 804 - 811. [Full Text] [PDF] |
||||
![]() |
H. Si, W.-T. Heyken, S. E. Wolfle, M. Tysiac, R. Schubert, I. Grgic, L. Vilianovich, G. Giebing, T. Maier, V. Gross, et al. Impaired Endothelium-Derived Hyperpolarizing Factor-Mediated Dilations and Increased Blood Pressure in Mice Deficient of the Intermediate-Conductance Ca2+-Activated K+ Channel Circ. Res., September 1, 2006; 99(5): 537 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Brekke, W. F. Jackson, and S. S. Segal Arteriolar smooth muscle Ca2+ dynamics during blood flow control in hamster cheek pouch J Appl Physiol, July 1, 2006; 101(1): 307 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Feletou and P. M. Vanhoutte Endothelium-Derived Hyperpolarizing Factor: Where Are We Now? Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1215 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Jackson Silent Inward Rectifier K+ Channels in Hypercholesterolemia Circ. Res., April 28, 2006; 98(8): 982 - 984. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |